Mantle cell lymphoma (MCL) typically presents with lymphadenopathy, bone marrow involvement, and splenomegaly; however, extra-nodal involvement, including the gastrointestinal tract, is only recently being increasingly recognized. The exact incidence of GI involvement in MCL varies across studies, ranging from approximately 15% to 30%, emphasizing the importance of considering this possibility in diagnosing patients with MCL [1].
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: